FutureChem Co.,Ltd (220100.KQ)

KRW 18200.0

(0.94%)

Total Debt Summary of FutureChem Co.,Ltd

  • FutureChem Co.,Ltd's latest annual total debt in 2023 was 3.68 Billion KRW , down -69.34% from previous year.
  • FutureChem Co.,Ltd's latest quarterly total debt in 2024 Q2 was 3.19 Billion KRW , down -7.19% from previous quarter.
  • FutureChem Co.,Ltd reported annual total debt of 12.01 Billion KRW in 2022, down -35.59% from previous year.
  • FutureChem Co.,Ltd reported annual total debt of 18.65 Billion KRW in 2021, down -17.8% from previous year.
  • FutureChem Co.,Ltd reported quarterly total debt of 3.44 Billion KRW for 2024 Q1, down -6.41% from previous quarter.
  • FutureChem Co.,Ltd reported quarterly total debt of 3.68 Billion KRW for 2023 FY, down -69.34% from previous quarter.

Annual Total Debt Chart of FutureChem Co.,Ltd (2023 - 2016)

Historical Annual Total Debt of FutureChem Co.,Ltd (2023 - 2016)

Year Total Debt Total Debt Growth
2023 3.68 Billion KRW -69.34%
2022 12.01 Billion KRW -35.59%
2021 18.65 Billion KRW -17.8%
2020 22.68 Billion KRW -36.51%
2019 35.73 Billion KRW -14.81%
2018 41.95 Billion KRW 749.97%
2017 4.93 Billion KRW 393.55%
2016 1 Billion KRW 0.0%

Peer Total Debt Comparison of FutureChem Co.,Ltd

Name Total Debt Total Debt Difference
HLB Pharmaceutical Co., Ltd 23.72 Billion KRW 84.48%
CMG Pharmaceutical Co., Ltd. 19.74 Billion KRW 81.348%
Celltrion Pharm, Inc. 162.52 Billion KRW 97.734%
Huons Global Co., Ltd. 254.93 Billion KRW 98.556%
DongKook Pharmaceutical Co., Ltd. 104.74 Billion KRW 96.484%
Enzychem Lifesciences Corporation 5.65 Billion KRW 34.903%
Humedix Co., Ltd. 2.7 Billion KRW -36.302%
Boditech Med Inc. 10.56 Billion KRW 65.153%
EuBiologics Co., Ltd. 14.77 Billion KRW 75.082%
Huons Co., Ltd. 124.61 Billion KRW 97.045%
BNC Korea Co., Ltd. 737.2 Million KRW -399.527%
AptaBio Therapeutics Inc. 13.93 Billion KRW 73.572%